SIRT7生物学功能及其与肿瘤发生发展关系的研究进展
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金(81972003);广东省自然科学基金(2017A030313668)。


Progress in the biological function of SIRT7 and its development in tumorigenesis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    SIRT7是烟酰胺腺嘌呤二核苷酸(nicotinamide adenine dinucleotide,NAD+)依赖蛋白去乙酰化酶,对组蛋白H3的第18位赖氨酸残基(H3K18ac)有特异性去乙酰化作用。作为Sirtuins蛋白家族的成员之一,SIRT7是许多细胞活动的关键介质。越来越多的证据表明SIRT7的基本细胞程序功能对于致癌演变以及肿瘤生物学有重要的影响,因此SIRT7有望成为表观遗传药物治疗新靶点。

    Abstract:

    SIRT7 is a member of the nicotinamide adenine dinucleotide(NAD+)-dependent protein deacetylase sirtuin family and a highly specific deacetylation of H3 K18 Ac(acetylated 18-position lysine residue of histone H3). Enzymes are key mediators of many cellular activities. There is increasing evidence that the basic cellular procedural function of SIRT7 has an important impact on oncogenic transformation and tumor biology, so SIRT7 is expected to become a new target for epigenetic drug therapy. Here, we describe the biological role of SIRT7 and summarize the key role of SIRT7 in various types of tumors.

    参考文献
    相似文献
    引证文献

引用格式:

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数: